Curada is building the first FDA-cleared digital therapeutic to reverse endorphin-based compulsions — starting with alcohol misuse.
The protocol behind it — once buried in a Finnish state lab — now holds 125 studies, 93% success, and full medical licensing in the UK/EU.
Still, it’s absent from U.S. standard of care — despite an 800% surge in alcohol-related deaths and $260B in annual harm.
We’re changing that — fast.
Curada integrates medical eligibility, digital prescribing, AI protocol guidance, and automated adherence into a seamless, scalable platform.
A 30K-strong grassroots community of adopters, clinicians, and advocates is shifting the paradigm — from abstinence to Nobel-recognized extinction.
Backed by Techstars London, we’re pursuing FDA Breakthrough Device Designation and scaling DTC in the UK — unlocking a 770M-person global market failed by pre-science treatment.
This is behavior neuroengineering — at scale.
📍 HQ: NYC
💥 $1.1M bridge-to-seed round open (Q3 2025)
Company Details
- Founded
- -
- Address
- London, Gb
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- http://www.curada.com
- Keywords
- AI, Peer Support, Healthtech, Digital Therapeutic.
- HQ
- London
Curada Questions
Curada's website is http://www.curada.com
Curada's LinkedIn profile is https://uk.linkedin.com/company/hellocurada
Curada's industry is
Software Development
Curada's top competitors are
Fan.io,
Eazytech,
Exclaim Innovations!,
Playburgh Game Studios,
Uis Tooling & Technologies,
Growthpilot,
Revista Inversión Inmobiliaria®,
Aven & Co.,
Immomailbox,
Pphf.
Curada's categories are Software Development
Curada's founding year is 2023
